Product Recalls in District of Columbia

Product recalls affecting District of Columbia — including food, drugs, consumer products, medical devices, and vehicles distributed to District of Columbia. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,622 recalls have been distributed to District of Columbia in the last 12 months.

47,654 total recalls
2,622 in last 12 months

Showing 64016420 of 13,355 recalls

DrugAugust 21, 2018· Auro Pharmacies, Inc.

Recalled Item: Glutathione injectable Recalled by Auro Pharmacies, Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility: Inadequate processes and equipment to assure...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 21, 2018· Auro Pharmacies, Inc.

Recalled Item: Dexpanthenol injectable Recalled by Auro Pharmacies, Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility: Inadequate processes and equipment to assure...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 21, 2018· Auro Pharmacies, Inc.

Recalled Item: CoEnzyme-Q10 injectable Recalled by Auro Pharmacies, Inc. Due to Lack of...

The Issue: Lack of Assurance of Sterility: Inadequate processes and equipment to assure...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 20, 2018· Hetero Labs Limited Unit V

Recalled Item: Montelukast Sodium Tablets Recalled by Hetero Labs Limited Unit V Due to...

The Issue: Discoloration: A complaint was received from a pharmacist for the presence...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine Recalled by Torrent Pharma Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets Recalled by Torrent Pharma Inc. Due to CGMP...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 15, 2018· Hetero Labs Limited Unit V

Recalled Item: Montelukast Sodium Tablets 10 mg Recalled by Hetero Labs Limited Unit V Due...

The Issue: Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugAugust 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets Recalled by AVKARE Inc. Due to CGMP Deviations: Carcinogen...

The Issue: CGMP Deviations: Carcinogen impurity detected in API used to manufacture...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund